NEW YORK (GenomeWeb News) – Prodesse has licensed Invitrogen’s LUX PCR reagents for use in molecular diagnostics, the companies said on Friday.
 
The agreement marks the first use of the LUX (Light Upon eXtension) PCR chemistries in diagnostic assays, the companies said.
 
Invitrogen said that the LUX reagents can be used in gene expression studies, biomarker analysis, and functional genomics experiments and enable users to examine multiple targets in one experiment.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.